Detalhe da pesquisa
1.
Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer.
Cancer Immunol Immunother
; 70(6): 1735-1743, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33388995
2.
Use of a Humanized Anti-CD6 Monoclonal Antibody (Itolizumab) in Elderly Patients with Moderate COVID-19.
Gerontology
; 66(6): 553-561, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33105142
3.
An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.
Immun Ageing
; 17(1): 34, 2020 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33292350
4.
Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients.
Cancer Immunol Immunother
; 65(1): 37-45, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26589409
5.
Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
Front Oncol
; 12: 823287, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35155258
6.
Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC.
Front Oncol
; 12: 958043, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35992783
7.
An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases.
Immunotherapy
; 13(4): 289-295, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33397150
8.
Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis.
J Exp Med
; 199(5): 649-59, 2004 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14981115
9.
Anti-EGF antibodies as surrogate biomarkers of clinical efficacy in stage IIIB/IV non-small-cell lung cancer patients treated with an optimized CIMAvax-EGF vaccination schedule.
Oncoimmunology
; 9(1): 1762465, 2020 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923124
10.
Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.
Clin Transl Immunology
; 9(11): e1218, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33304584
11.
Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.
Clin Cancer Res
; 14(3): 840-6, 2008 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18245547
12.
Biomodulina T partially restores immunosenescent CD4 and CD8 T cell compartments in the elderly.
Exp Gerontol
; 124: 110633, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31207285
13.
Nimotuzumab: beyond the EGFR signaling cascade inhibition.
Semin Oncol
; 45(1-2): 18-26, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30318080
14.
CIMAvax-EGF: Toward long-term survival of advanced NSCLC.
Semin Oncol
; 45(1-2): 34-40, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30318082
15.
Complete antitumor protection by perioperative immunization with GM3/VSSP vaccine in a preclinical mouse melanoma model.
Clin Cancer Res
; 12(23): 7092-8, 2006 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17145833
16.
Immunologic Response Elicited in Breast Cancer Patients Receiving a NeuGcGM3-based Vaccine as Adjuvant Therapy.
J Immunother
; 40(8): 289-301, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28604556
17.
Safety and Immunogenicity of a Human Epidermal Growth Factor Receptor 1 (HER1)-Based Vaccine in Prostate Castration-Resistant Carcinoma Patients: A Dose-Escalation Phase I Study Trial.
Front Pharmacol
; 8: 263, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28539888
18.
Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients.
Front Pharmacol
; 8: 382, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28674498
19.
Immunological evaluation of rheumatoid arthritis patients treated with itolizumab.
MAbs
; 8(1): 187-95, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26466969
20.
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients.
Clin Cancer Res
; 22(15): 3782-90, 2016 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26927662